Hong Kong Stock Movement: SHANGSHAN GOLD plummets 16.39%, active capital flow attracts market attention

Hong Kong Stock Movement SHANGSHAN GOLD fell 16.39%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Stocks with High Trading Volume in the Industry Lemo Technology fell 4.94%, with a trading volume of HKD 13.39 million, and no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Automobile Street rose 5.04%, with a trading volume of HKD 13.01 million, and no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Fushouyuan fell 0.35%. Based on recent key news: On December 17, the Ministry of Civil Affairs released the "Funeral Management Regulations (Draft for Comments)," raising market concerns about increased regulation in the funeral industry. This draft aims to standardize funeral services, which may lead to business adjustments for Fushouyuan, putting pressure on its stock price. On December 16, Guangdong's ecological burial rate exceeded 63%, indicating an accelerated development of green burial trends. As a traditional funeral service provider, Fushouyuan faces transformation pressure, affecting its stock price. On December 15, the Shanghai Civil Affairs Bureau announced the "List of Funeral Service Items in Shanghai," further clarifying service standards and prices, which may impact Fushouyuan's profitability, leading to a decline in its stock price. The funeral industry faces policy adjustments and green transformation. Stocks with High Market Capitalization in the Industry Meili Tianyuan Medical Health rose 0.15%. Based on recent key news: On December 20, Shenwan Hongyuan analysts maintained a buy rating for Meili Tianyuan Medical Health, setting a target price of HKD 37.13. The analyst consensus is strong buy, with an average target price of HKD 38.83, indicating increased market confidence in the company, driving the stock price up. The Hong Kong stock market has shown stable performance recently, with evident capital inflow